4
Changes in Ownership
PALISADE BIO, INC. Filed Acc 0001493152-23-039936
CEO, CFO, Director acquired 3,475 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Finley John David CEO, CFO, Director | 2023-11-06 | Option exercise | +3,475 | 47,781 | D | ||
| Derivatives | |||||||
| Finley John David CEO, CFO, Director | 2023-11-06 | Option exercise · Restricted Stock Units | −3,475 | 31,275 | D | ||
Loading xslF345X05/ownership.xml…